Latest From Biotech Now

JOBS Act Deconstructed: Regulatory Relief

Capitol

More than 40 biotech companies have gone public using provisions made available to emerging growth companies through the JOBS Act. BIOtechNOW’s JOBS Act Deconstructed series will explore why it has had such an impact on biotech offerings and how emerging companies can leverage the new law to their best advantage. The JOBS Act marks a key departure from the previous one-size-fits-all regulatory approach for companies conducting a public offering.  Emerging growth companies (EGCs) are now subject Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , ,

The New Demand for Biotech Industry Talent

scientists115x76

Biotechnology is a multi-disciplinary field involving the integration of knowledge and skills drawn from numerous disciplines, such as microbiology, biochemistry, genetics, molecular biology and chemistry. Traditionally, the field of biotechnology has required a workforce with a wide array of highly specialized skills and training. Interestingly though, a shift has begun to take place, favoring people with interdisciplinary academic training who can support more than one project team and work across multiple areas. On September 10, Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: ,

Uniting To Accelerate Pediatric Medicine

Erik_Halvorsen

Drug companies inherently absorb significant risk when developing compounds and biologics for clinical use. A recent article suggests that only one out of every 12 drugs that enters clinical trials succeeds and the cost of a drug successfully reaching the market now exceeds an average of $5 billion when you add up the cost of all those that failed along the way. For many indications, such as Alzheimer’s and autism, the need for new treatments Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

The Costly Consequences of I-522

No-on-522-2 copy

Washington Research Council Reveals the Whole Story Behind Washington State’s Initiative 522, and Yes it Will Cost You a Dime Many Washington state residents know that on November 5, 2013, they will have to vote on whether or not to pass state Initiative 522, which will require special labels on certain foods made with genetically engineered (GE) ingredients.  What many residents don’t know is that a “yes” vote can lead to many costly consequences for Read More >

Food And Agriculture  |  Leave a comment  |  Email This Post
Tags: , , , , ,

JOBS Act Deconstructed: Regulation D

150639480

More than 40 biotech companies have gone public using provisions made available to emerging growth companies through the JOBS Act.  BIOtechNOW’s JOBS Act Deconstructed series will explore why it has had such an impact on biotech offerings and how emerging companies can leverage the new law to their best advantage.  Since the JOBS Act passed, attention has focused mostly on the law’s effects on the IPO market.  This is largely because the IPO On-Ramp was the Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , ,